000 | 01255 a2200349 4500 | ||
---|---|---|---|
005 | 20250515093314.0 | ||
264 | 0 | _c20080124 | |
008 | 200801s 0 0 eng d | ||
022 | _a1570-1638 | ||
024 | 7 |
_a10.2174/157016307782109652 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSampath, Janardhan | |
245 | 0 | 0 |
_aAlternative splice variants of survivin as potential targets in cancer. _h[electronic resource] |
260 |
_bCurrent drug discovery technologies _cOct 2007 |
||
300 |
_a174-91 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAlternative Splicing |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aGenetic Therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 | _aInhibitor of Apoptosis Proteins |
650 | 0 | 4 |
_aMicrotubule-Associated Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aNeoplasm Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aNeoplasms _xgenetics |
650 | 0 | 4 |
_aOligonucleotides, Antisense _xgenetics |
650 | 0 | 4 | _aRepressor Proteins |
650 | 0 | 4 | _aSurvivin |
700 | 1 | _aPelus, Louis M | |
773 | 0 |
_tCurrent drug discovery technologies _gvol. 4 _gno. 3 _gp. 174-91 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/157016307782109652 _zAvailable from publisher's website |
999 |
_c17503896 _d17503896 |